位置:首页 > 蛋白库 > CDND2_ENTCL
CDND2_ENTCL
ID   CDND2_ENTCL             Reviewed;         381 AA.
AC   P0DSP4;
DT   18-SEP-2019, integrated into UniProtKB/Swiss-Prot.
DT   18-SEP-2019, sequence version 1.
DT   03-AUG-2022, entry version 10.
DE   RecName: Full=Cyclic AMP-AMP-GMP synthase {ECO:0000305|PubMed:30787435};
DE            EC=2.7.7.- {ECO:0000269|PubMed:30787435};
DE   AltName: Full=cGAS/DncV-like nucleotidyltransferase {ECO:0000303|PubMed:30787435};
DE            Short=CD-NTase038 {ECO:0000303|PubMed:30787435};
GN   Name=cdnD02 {ECO:0000303|PubMed:30787435};
GN   ORFNames=P853_02262 {ECO:0000312|EMBL:EUL38999.1};
OS   Enterobacter cloacae.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Enterobacter; Enterobacter cloacae complex.
OX   NCBI_TaxID=550;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=UCI 50;
RG   The Broad Institute Genomics Platform;
RG   The Broad Institute Genome Sequencing Center for Infectious Disease;
RA   Murphy C., Cosimi L., Cerqueira G., Feldgarden M., Earl A., Hung D.,
RA   Onderdonk A.B., Ferraro M.J., Hooper D., Dekker J., O'Brien T., Huang S.,
RA   Quan V., Ernst C., Delaney M., DuBois A., Kim D.S., Young S.K., Zeng Q.,
RA   Gargeya S., Fitzgerald M., Abouelleil A., Alvarado L., Berlin A.M.,
RA   Chapman S.B., Gainer-Dewar J., Goldberg J., Gnerre S., Griggs A., Gujja S.,
RA   Hansen M., Howarth C., Imamovic A., Ireland A., Larimer J., McCowan C.,
RA   Murphy C., Pearson M., Poon T.W., Priest M., Roberts A., Saif S., Shea T.,
RA   Sykes S., Wortman J., Nusbaum C., Birren B.;
RT   "The Genome Sequence of Enterobacter cloacae UCI 50.";
RL   Submitted (JAN-2014) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, NOMENCLATURE, AND SIMILARITY.
RC   STRAIN=UCI 50;
RX   PubMed=30787435; DOI=10.1038/s41586-019-0953-5;
RA   Whiteley A.T., Eaglesham J.B., de Oliveira Mann C.C., Morehouse B.R.,
RA   Lowey B., Nieminen E.A., Danilchanka O., King D.S., Lee A.S.Y.,
RA   Mekalanos J.J., Kranzusch P.J.;
RT   "Bacterial cGAS-like enzymes synthesize diverse nucleotide signals.";
RL   Nature 567:194-199(2019).
RN   [3]
RP   ANTIVIRAL DEFENSE, OPERON STRUCTURE, AND MUTAGENESIS OF 69-ASP--ASP-71.
RC   STRAIN=UCI 50;
RX   PubMed=32544385; DOI=10.1016/j.cell.2020.05.019;
RA   Lowey B., Whiteley A.T., Keszei A.F.A., Morehouse B.R., Antine S.P.,
RA   Cabrera V.J., Kashin D., Schwede F., Mekalanos J.J., Shao S., Lee A.S.Y.,
RA   Kranzusch P.J.;
RT   "CBASS immunity uses CARF-related effectors to sense 3'-5' and 2'-5'-linked
RT   cyclic oligonucleotide signals and protect bacteria from phage infection.";
RL   Cell 182:38-49(2020).
RN   [4]
RP   CLASSIFICATION AND NOMENCLATURE.
RX   PubMed=32839535; DOI=10.1038/s41564-020-0777-y;
RA   Millman A., Melamed S., Amitai G., Sorek R.;
RT   "Diversity and classification of cyclic-oligonucleotide-based anti-phage
RT   signalling systems.";
RL   Nat. Microbiol. 5:1608-1615(2020).
CC   -!- FUNCTION: CBASS (cyclic oligonucleotide-based antiphage signaling
CC       system) provides immunity against bacteriophage. The CD-NTase protein
CC       synthesizes cyclic nucleotides in response to infection; these serve as
CC       specific second messenger signals. The signals activate a diverse range
CC       of effectors, leading to bacterial cell death and thus abortive phage
CC       infection. A type II-C(AAG) CBASS system (PubMed:32839535).
CC       {ECO:0000269|PubMed:32544385, ECO:0000303|PubMed:32839535}.
CC   -!- FUNCTION: Cyclic trinucleotide synthase that catalyzes the synthesis of
CC       3',3',3'-cyclic AMP-AMP-GMP as the major product, a second messenger
CC       for cell signal transduction. {ECO:0000269|PubMed:30787435}.
CC   -!- FUNCTION: Protects E.coli against phage T2 infection. When the cdnD-
CC       cap2-cap3-cap4 operon is introduced in E.coli there is a more than
CC       10(3) decrease in the efficiency of T2 plaque formation. The operon
CC       does not protect against phage T5 and only about 10-fold against T7.
CC       {ECO:0000269|PubMed:32544385}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 ATP + GTP = cyclic AMP-AMP-GMP + 3 diphosphate;
CC         Xref=Rhea:RHEA:60476, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:37565, ChEBI:CHEBI:143810;
CC         Evidence={ECO:0000269|PubMed:30787435};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60477;
CC         Evidence={ECO:0000305|PubMed:30787435};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:G2SLH8};
CC       Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000250|UniProtKB:G2SLH8};
CC   -!- INDUCTION: Part of the CBASS operon consisting of cap4-cdnD-cap2-cap3.
CC       {ECO:0000305|PubMed:32544385}.
CC   -!- SIMILARITY: Belongs to the CD-NTase family. D02 subfamily.
CC       {ECO:0000305|PubMed:30787435}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; JCKK01000002; EUL38999.1; -; Genomic_DNA.
DR   PDB; 7D48; X-ray; 2.15 A; A=1-381.
DR   PDB; 7D4J; X-ray; 2.09 A; A=1-381.
DR   PDB; 7D4O; X-ray; 1.87 A; A/B=1-381.
DR   PDB; 7D4S; X-ray; 1.93 A; A=1-381.
DR   PDB; 7D4U; X-ray; 2.70 A; A=1-381.
DR   PDB; 7LJL; X-ray; 1.45 A; A/B=1-381.
DR   PDBsum; 7D48; -.
DR   PDBsum; 7D4J; -.
DR   PDBsum; 7D4O; -.
DR   PDBsum; 7D4S; -.
DR   PDBsum; 7D4U; -.
DR   PDBsum; 7LJL; -.
DR   AlphaFoldDB; P0DSP4; -.
DR   SMR; P0DSP4; -.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016779; F:nucleotidyltransferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   GO; GO:0009117; P:nucleotide metabolic process; IEA:UniProtKB-KW.
DR   InterPro; IPR043519; NT_sf.
DR   SUPFAM; SSF81301; SSF81301; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antiviral defense; ATP-binding; GTP-binding; Magnesium;
KW   Metal-binding; Nucleotide metabolism; Nucleotide-binding;
KW   Nucleotidyltransferase; Transferase.
FT   CHAIN           1..381
FT                   /note="Cyclic AMP-AMP-GMP synthase"
FT                   /id="PRO_0000447704"
FT   REGION          348..381
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         69
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:G2SLH8"
FT   BINDING         71
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:G2SLH8"
FT   BINDING         157
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:G2SLH8"
FT   MUTAGEN         69..71
FT                   /note="DVD->AVA: No longer protects against phage T2."
FT                   /evidence="ECO:0000269|PubMed:32544385"
FT   HELIX           4..14
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   HELIX           18..37
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   HELIX           39..41
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   TURN            42..44
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   STRAND          45..51
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   HELIX           52..55
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   STRAND          69..76
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   TURN            80..82
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   HELIX           85..90
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   HELIX           93..99
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   STRAND          103..107
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   STRAND          110..114
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   STRAND          119..126
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   HELIX           131..141
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   HELIX           144..147
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   HELIX           152..154
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   HELIX           184..186
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   TURN            187..189
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   STRAND          192..195
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   STRAND          197..205
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   HELIX           207..220
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   TURN            221..223
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   HELIX           225..238
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   HELIX           240..242
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   HELIX           249..259
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   HELIX           267..281
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   HELIX           283..287
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   STRAND          297..299
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   TURN            304..307
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   HELIX           310..332
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   HELIX           336..347
FT                   /evidence="ECO:0007829|PDB:7LJL"
FT   HELIX           348..350
FT                   /evidence="ECO:0007829|PDB:7LJL"
SQ   SEQUENCE   381 AA;  43256 MW;  7FF5909D6F0B7470 CRC64;
     MELQPQFNEF LANIRPTDTQ KEDWKSGART LRERLKNFEP LKEIVVSTFL QGSIRRSTAI
     RPLGDKRPDV DIVVVTNLDH TRMSPTDAMD LFIPFLEKYY PGKWETQGRS FGITLSYVEL
     DLVITAIPES GAEKSHLEQL YKSESVLTVN SLEEQTDWRL NKSWTPNTGW LSESNSAQVE
     DAPASEWKAH PLVLPDREKN EWGRTHPLAQ IRWTAEKNRL CNGHYINLVR AVKWWRQQNS
     EDLPKYPKGY PLEHLIGNAL DNGTTSMAQG LVQLMDTFLS RWAAIYNQKS KPWLSDHGVA
     EHDVMARLTA EDFCSFYEGI ASAAEIARNA LASEEPQESA QLWRQLFGSK FPLPGPQGGD
     RNGGFTTPSK PAEPQKTGRF A
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024